Emergent BioSolutions Inc (NYSE: EBS) stock suffered a major decline of -11.1% on 9/3/24. The shares closed at $7.39. NORMAL trading volume accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -22.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, EBS is expected to be a major Value Builder.
Emergent BioSolutions has a current Value Trend Rating of A (Highest Rating). This rating combines complementary signals from two proprietary PTR measures of a stock’s attractiveness. Emergent BioSolutions has a slightly positive Appreciation Score of 65 and a very high Power Rating of 93, resulting in the Highest Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment